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Introduction  
Mesocircuit fronto-parietal model  
Giacino, Fins, Laureys, Schiff, Nature Rev Neurol 2014 
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Amantadine 
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Giacino et al, N Engl J Med, 2012  
n=184 
Schnakers et al, JNNP, 2008 
Dopaminergic agent  
(Parkinson)  
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Whyte & Meyers, 2009 
1/15 responders   
= 6.7%  
4/84 responders   
=5% 
Whyte et al, 2014 
4/60 responders  
= 6.7% no change of diagnosis 
Thonnard & Gosseries et al, 2014 
 
 
 Diagnostic 1 week assessment at the Hopital of 
Liege for DOC patients 
Short-acting nonbenzodiazepine GABA-A agonist hypnotic 
Zolpidem 
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Chatelle & Thibaut, et al., Front Hum Neurosci, 2014 
N=3 
www.comascience.org 
disorders of consciousness | behavioural evaluation | electrophysiology | neuroimaging | methods, ethics & quality of life | perspectives  
Deep brain stimulation 
Schiff et al, Nature, 2007 
Giacino et al, Neurmodulation, 2012 
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Intralaminar nuclei stimulation 
induces “recovery” from  
minimally responsive state  
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Deep brain stimulation 
Schiff et al, Nature, 2007 













































































Eyes Open w/o Stim 
Eyes Open w/ Stim 
Functional Object Use 
Object Manipulation 
Automatic Movement 






Why tDCS?  
 Cheap, easy to use & no severe side-effects 
Stimulation Population  Effects Authors 
Motor cortex Healthy subjects Dexterity Boggio et al. Neurosci Lett, 
2006 
Hemiplegic patients Dexterity and 
strength 
Hummel et al. Lancet, 
2006 
Spastic patients Spasticity & ADL 
(activity of daily life) 




Healthy subjects Memory Marshall et al. J Neurosci, 
2004 
Alzheimer’s patients Memory Ferrucci et al. Neurology, 
2008 
Stroke patients Attention Jo et al. Am J Phys Med 
Rehabil, 2009 
Aphasic patients Language Baker et al. Stroke, 2010 
Thibaut et al, Rev Neurol, 2013 
Drugs | DBS | tDCS 1 | Conclusion 
www.comascience.org 
disorders of consciousness | behavioural evaluation | electrophysiology | neuroimaging | methods, ethics & quality of life | perspectives  
tDCS single session 
• Randomized, double blind, sham controlled, cross-
over study 
• Direct current; 2 mA; 20 min 
• 55 patients included                          
(25 VS/UWS; 30 MCS;                                    






Thibaut et al., Neurology, 2014 
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CRS-R CRS-R CRS-R CRS-R 
tDCS tDCS 
20’ 20’ 48h 
 session 1              session 2 
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tDCS single session 
MCS (n=30) VS/UWS (n=25) 
Treatment effect: delta CRS-R total scores 



















































* ns * p<0.05 
Thibaut et al., Neurology, 2014 
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tDCS single session 
• 15/55 responders : sign of consciousness after 
tDCS and not before tDCS or before and after sham 
o 2 VS/UWS; acute 
o 13 MCS (5 patients >1y post insult) 
• Change of diagnosis 
o 3 MCS  EMCS (acute) 
o 2 VS/UWS  MCS (acute) 
• No effect of time since injury or etiology 
• No side effects 
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Neural correlates  
 
 
 Can functional brain activity & grey matter 
atrophy predict tDCS clinical response? 
 
 
Thibaut & Di Perri et al., under review 
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• Data from study 1 – chronic MCS (n=24) 
• FDG-PET – MRI (VBM) 
• 8 tDCS responders (4 TBI, mean age: 38±19y)  
   13 tDCS non-responders (8 TBI, mean age:36±14y) 
PET/MRI 
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Single stimulation: effects ± 60 min1  
 short-lasting improvements, back to initial state  
1. Increase the duration of the effects 





1Nitsche et al., 2001 
Thibaut et al., submitted 
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Randomized sham controlled double blind cross-over 
16 patients included in chronic MCS (12TBI; mean age 47±16y) 


















Treatment effect: day5 & day 12 – 53% of responders 





















































day 5 day 12 
* 
* p<0.05 
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Repeated stimulations 
• Longitudinal analysis: 
o Real session: significant + time evolution (p<0.001)  










Drugs | DBS | tDCS 3 | Conclusion 
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Conclusion  
mesocircuit fronto-parietal model  
Giacino, Fins, Laureys, Schiff, Nature Rev Neurol 2014 
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